- Home
- JSPR vs XYF Comparison
JSPR vs XYF Comparison
Compare JSPR & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JSPR | XYF |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 181.0M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | JSPR | XYF |
|---|---|---|
| Price | $0.59 | $4.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 337.8K | 70.0K |
| Earning Date | 11-09-2026 | 11-19-2026 |
| Dividend Yield | N/A | ★ 11.34% |
| EPS Growth | ★ 19.22 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.90 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.32 | $3.30 |
| 52 Week High | $2.69 | $14.65 |
Technical Indicators
Market Signals| Indicator | JSPR | XYF |
|---|---|---|
| Relative Strength Index (RSI) | 42.15 | 44.63 |
| Support Level | $0.55 | $4.98 |
| Resistance Level | $0.60 | $5.15 |
| Average True Range (ATR) | 0.06 | 0.25 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 32.18 | 46.83 |
Price Performance
Historical ComparisonAbout JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, guarantee services provided and financing income.